<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0010">
 <label>Table 2</label>
 <caption>
  <p>Binding energy scores and molecular interactions between top 5 leads and SARS-CoV M
   <sup>pro</sup>. The figures in bracket indicate the hydrogen bond length.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">ZINC ID</th>
    <th rowspan="2">Common Name</th>
    <th rowspan="2">Structure</th>
    <th rowspan="2">Binding Energy (kcal/mol)</th>
    <th colspan="2">Molecular Interactions
     <hr/>
    </th>
   </tr>
   <tr>
    <th>Hydrogen bonds</th>
    <th>Hydrophobic interactions</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>ZINC000026985532</td>
    <td>Saquinavir</td>
    <td>
     <inline-graphic xlink:href="fx7.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
    <td>−9.6</td>
    <td>O6…..N(Glu166) [2.83 Å]
     <break/>N5…..OE1(Gln189) [3.06 Å]
     <break/>O2…..O(Leu141) [2.75 Å]
     <break/>O1…..N(Gly143) [2.89 Å]
    </td>
    <td>Thr25,Thr26, His41,Met49, Phe140, Asn142, Cys145, His164, Met165, Leu167, Thr190 and Gln192 (N = 12)</td>
   </tr>
   <tr>
    <td>ZINC000052955754</td>
    <td>Ergotamine</td>
    <td>
     <inline-graphic xlink:href="fx8.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
    <td>−9.5</td>
    <td>O1…..N(Gly143)
     <break/>O4…..N(Gly143)
    </td>
    <td>Thr25, His41, Met49, Asn142, Cys145, His164, Met165, Glu166 and Gln189 (N = 9)</td>
   </tr>
   <tr>
    <td>ZINC000006716957</td>
    <td>Nilotinib</td>
    <td>
     <inline-graphic xlink:href="fx9.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
    <td>−9.4</td>
    <td>N4…..OD(Asn142) [3.03 Å]
     <break/>N1…..O(His164) [3.15 Å]
    </td>
    <td>Thr25, His41, Cys44, Met49, Phe140, Cys145, His163, Met165, Glu166 and Gln189 (N = 10)</td>
   </tr>
   <tr>
    <td>ZINC000013831130</td>
    <td>Raltegravir</td>
    <td>
     <inline-graphic xlink:href="fx10.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
    <td>−9.2</td>
    <td>O4…..O(His41) [2.95 Å]
     <break/>O2…..N(Cys145) [3.25 Å]
     <break/>N5…..OD1 (Asn142) [2.83 Å]
    </td>
    <td>Thr25, Thr26, Leu27, Cys44, Met49, Leu141, Gly143, Asp187, Arg188 and Gln189, (N = 10)</td>
   </tr>
   <tr>
    <td>ZINC000003978005</td>
    <td>Dihydroergotamine</td>
    <td>
     <inline-graphic xlink:href="fx11.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
    <td>−9.2</td>
    <td>O4…..N(Ser144) [3.34 Å]
     <break/>O4…..N(Gly143) [2.67 Å]
     <break/>O1…..N(Gly143) [2.98 Å]
    </td>
    <td>Thr25, Leu27, His41, Cys44, Met49, Asn142, Cys145, His164, Met165, Glu166 and Gln189 (N = 11)</td>
   </tr>
   <tr>
    <td>Control (G85)</td>
    <td>SG85</td>
    <td>
     <inline-graphic xlink:href="fx12.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
    <td>−7.9</td>
    <td>O19…..N(Cys145) [3.20 Å]
     <break/>O19…..SG(Cys145) [3.28 Å]
     <break/>N49…..OE1(Gln189) [2.89 Å]
     <break/>O47…..N(Glu166) [3.02 Å]
    </td>
    <td>Thr25, Thr26, His41, Met49, Phe140, Leu141, Asn142, Gly143, Ser144, His163, His164, Met165, Asp187, Thr190, Ala191 and Gln192 (N = 16)</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
